Zinc Acetate Dihydrate Granule
NDC Package 72402-001-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Zinc Acetate Dihydrate granules is a medication used after other medications to treat a certain liver disease (Wilson's disease). This formulation utilizes a granule delivery system. Marketed by Magnesium Products, Inc., this product is identified by NDC 72402-001.

Identification & Billing

NDC Package Code
72402-001-50
Package Description
50 kg in 1 BAG
Product Code
72402-001
11-Digit Billing Format
72402000150

Clinical Specifications

Proprietary Name
Zinc Acetate Dihydrate
Non-Proprietary Name
Zinc Acetate Dihydrate
Substance Name
Zinc Acetate
Dosage Form
Granule - A small particle or grain.
Active Ingredient(s)
ZINC ACETATE 50 kg/50kg
Usage Information
This medication is used after other medications to treat a certain liver disease (Wilson's disease). This inherited disease causes the liver to hold onto too much copper, resulting in liver damage and other serious problems. This medication causes the intestines to make more of a certain substance (a protein) that prevents the body from absorbing too much copper from food, thereby preventing further damage.

Regulatory & Marketing

Labeler Name
Magnesium Products, Inc.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
07-10-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72402-001-50 identifies a specific commercial package of 50 kg in 1 bag of Zinc Acetate Dihydrate (UNFINISHED drug), a bulk ingredient labeled by Magnesium Products, Inc.. This granule is formulated for use and contains zinc acetate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Magnesium Products, Inc. on July 10, 2019. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used after other medications to treat a certain liver disease (Wilson's disease). This inherited disease causes the liver to hold onto too much copper, resulting in liver damage and other serious problems. This medication causes the intestines to make more of a certain substance (a protein) that prevents the body from absorbing too much copper from food, thereby preventing further damage.

How is this Magnesium Products, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72402000150. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72402-001-50
11-Digit CMS (5-4-2)
72402-0001-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.